Trice Medical, a private diagnostic company focused on micro invasive technologies, is pioneering needle-based diagnostic and therapeutic technologies for orthopedics.
Today, we announced that Trice raised $11.6 billion in a Series B financing, which was led by Safeguard with participation from BioStar Ventures and other existing investors.
Proceeds from the funding will support Trice’s efforts to commercialize and market [...]
Managing ‘omics data—or the technologies used to explore the roles, relationships and actions of the various types of molecules that make up the cells of an organism such as genomics, proteomics or metabolomics—presents a challenge across the healthcare paradigm. In response, Syapse, Inc. developed a comprehensive Precision Medicine Data Platform that makes genomic, molecular, and clinical data actionable for [...]Posted by Gary J. Kurtzman, MD
Revolutionary changes in industries like healthcare would never be possible without new information technologies, one of Safeguard’s sweet spots dating back to our early days when we were nurturing and developing companies like Novell, CompuCom, QVC, Cambridge Technology Partners and ICG.
Sweeping innovations such as big data, cloud computing and Software as a Service (SaaS) are [...]
No industry is more ripe for change than healthcare in the America. Hindered by payer models that for too long rewarded procedures and prescriptions, healthcare is now transforming under new approaches that place patients at the center of the healthcare ecosystem and elevate quality and outcomes over quantity and volume.
This new focus represents a genuine [...]
It was a rainy, dreary day yesterday. But thanks to MANNA, many people with life-threatening illnesses didn’t need to venture into the damp cold to buy groceries. The non-profit organization cooks and delivers nutritious, medically appropriate meals to people with cancer, renal disease, HIV/AIDS and other chronic conditions.
The Safeguard team got an up close [...]
Smart money–capital that flows to the greatest and highest purpose–is always predicated on opportunities of the future, tomorrow’s trends that are difficult to decipher in today’s chaos.
Ever since our founding in 1953, Safeguard has had the uncanny ability to seek out opportunity–to find the next big ‘thing’ and then create value through a unique blend [...]
“Study the past if you would define the future.”
Those were the words of the wise Confucius. And those are the words that remain in my mind on the heels of Safeguard’s 60th Anniversary.
In 2013, we had an amazing opportunity to embrace Safeguard’s six decade long history, in its entirety. In so doing, the year became [...]
In 2007, Alverix set out to revolutionize point-of-care (POC) testing–medical tests conducted in the doctor’s office, at a patient’s bedside, in a clinic or even in a patient’s home. POC testing offers convenience and swift results. But to be effective, the tests must be absolutely accurate. Alverix’s products, which leverage optoelectronics, offer portability and affordability [...]Posted by Gary J. Kurtzman, MD
Over the past 60 years, Safeguard Scientifics has demonstrated an unwavering commitment to innovation, which has ultimately improved people’s quality of life, boosted the economy and provided companies a better way to do business. Those products and services have evolved over the years, from cable TV to home shopping, office products and data processing to [...]Posted by Stephen T. Zarrilli
In February 2011—long before the term “Internet of Things” became a hot business buzzword—Safeguard Scientifics saw potential in ThingWorx, the first application platform that lets designers build and run Internet of Things (IoT) and Machine-to-Machine (M2M) applications. Since 2011, Safeguard has deployed $10 million in ThingWorx, which was founded in 2009 and based in Exton, [...]Posted by Erik B. Rasmussen
For sixty years, Safeguard has been supporting entrepreneurs and funding innovations that have had a transformative impact on our lives. Today, we continued that tradition by announcing that we led a $16 million Series C financing round for Apprenda, the leading enterprise Platform as a Service (PaaS) powering the next generation of enterprise software development in [...]Posted by Philip D. Moyer